Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,402.01
+2,941.55(+6.20%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Ono Pharmaceutical Co., Ltd. (4528.T)

Tokyo - Tokyo Delayed price. Currency in JPY

Add to watchlist

2,305.50

-18.50

(-0.80%)

At close: 03:15PM JST

Currency in JPY

Valuation measures⁴

Market cap (intra-day)	1.08T
Enterprise value	955.95B
Trailing P/E	8.73
Forward P/E	13.95
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	2.24
Price/book (mrq)	1.38
Enterprise value/revenue	1.92
Enterprise value/EBITDA	5.16

Trading information

Stock price history

Beta (5Y monthly)	0.20
52-week change ³	-15.60%
S&P500 52-week change ³	22.38%
52-week high ³	2,966.50
52-week low ³	2,232.50
50-day moving average ³	2,417.71
200-day moving average ³	2,613.96

Share statistics

Avg vol (3-month) ³	2.18M
Avg vol (10-day) ³	2.51M
Shares outstanding ⁵	469.71M
Implied shares outstanding ⁶	474.89M
Float ⁸	458.25M
% held by insiders ¹	15.55%
% held by institutions ¹	47.26%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	80
Forward annual dividend yield ⁴	3.47%
Trailing annual dividend rate ³	110.00
Trailing annual dividend yield ³	4.73%
5-year average dividend yield ⁴	2.04
Payout ratio ⁴	29.17%
Dividend date ³	N/A
Ex-dividend date ⁴	28 Mar 2024
Last split factor ²	5:1
Last split date ³	29 Mar 2016

Financial highlights

Fiscal year

Fiscal year ends	31 Mar 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	25.62%
Operating margin (ttm)	36.28%

Management effectiveness

Return on assets (ttm)	12.49%
Return on equity (ttm)	16.82%

Income statement

Revenue (ttm)	498.07B
Revenue per share (ttm)	1,029.06
Quarterly revenue growth (yoy)	7.30%
Gross profit (ttm)	N/A
EBITDA	190.01B
Net income avi to common (ttm)	127.61B
Diluted EPS (ttm)	263.98
Quarterly earnings growth (yoy)	8.20%

Balance sheet

Total cash (mrq)	135.56B
Total cash per share (mrq)	285.53
Total debt (mrq)	8.59B
Total debt/equity (mrq)	1.09%
Current ratio (mrq)	3.95
Book value per share (mrq)	1,652.77

Cash flow statement

Operating cash flow (ttm)	106.04B
Levered free cash flow (ttm)	76.67B